Simplex Trading’s Genocea Biosciences, Inc. GNCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-500
| Closed | – | – | 11536 |
|
|
2022
Q2 | $0 | Sell |
500
-8,476
| -94% | -$3.36K | ﹤0.01% | 11761 |
|
|
2022
Q1 | $11K | Sell |
8,976
-22,039
| -71% | -$24K | ﹤0.01% | 8838 |
|
|
2021
Q4 | $35K | Buy |
+31,015
| New | +$46.2K | ﹤0.01% | 7725 |
|
|
2021
Q1 | – | Sell |
-15,322
| Closed | -$45.4K | – | 10629 |
|
|
2020
Q4 | $37K | Buy |
+15,322
| New | +$34.9K | ﹤0.01% | 6484 |
|
|
2020
Q3 | – | Sell |
-236
| Closed | -$619 | – | 8997 |
|
|
2020
Q2 | $0 | Buy |
+236
| New | +$543 | ﹤0.01% | 8856 |
|
|
2020
Q1 | – | Sell |
-120
| Closed | -$242 | – | 8739 |
|
|
2019
Q4 | $0 | Sell |
120
-1,923
| -94% | -$4.56K | ﹤0.01% | 8461 |
|
|
2019
Q3 | $5K | Buy |
+2,043
| New | +$6.97K | ﹤0.01% | 6655 |
|
|
2018
Q4 | – | Sell |
-38
| Closed | – | – | 8340 |
|
|
2018
Q3 | $0 | Buy |
+38
| New | +$201 | ﹤0.01% | 8492 |
|
|
2017
Q4 | – | Sell |
-970
| Closed | -$9.75K | – | 7128 |
|
|
2017
Q3 | $11K | Buy |
970
+807
| +495% | +$30.6K | ﹤0.01% | 3735 |
|
|
2017
Q2 | $6K | Buy |
+163
| New | +$7.85K | ﹤0.01% | 4516 |
|
|
2017
Q1 | – | Sell |
-314
| Closed | -$12.3K | – | 7166 |
|
|
2016
Q4 | $10K | Buy |
314
+212
| +208% | +$6.98K | ﹤0.01% | 3783 |
|
|
2016
Q3 | $4K | Buy |
+102
| New | +$4K | ﹤0.01% | 4577 |
|
Other funds holding GNCA
Simplex Trading's GNCA Position: Q3 2022 in Review
Simplex Trading sold out of Genocea Biosciences, Inc. (GNCA) in Q3 2022, closing a stake of 500 shares.
Simplex Trading first reported a position in GNCA in Q3 2016 and held it in 12 quarters. The position peaked at $37K in Q4 2020. 1 fund tracked by Wall St. Rank holds GNCA as of Q3 2022.
- Simplex Trading reported no remaining Genocea Biosciences, Inc. position as of Q3 2022 after selling out during the quarter.
- Simplex Trading sold 500 Genocea Biosciences, Inc. shares in Q3 2022.
- Simplex Trading first reported a position in Genocea Biosciences, Inc. in Q3 2016 and held it in 12 quarters.
- Simplex Trading's Genocea Biosciences, Inc. position peaked at $37K in Q4 2020.
- 1 fund tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q3 2022.
Based on Simplex Trading's 13F filing for Q3 2022, filed 4 Nov 2022.